全文获取类型
收费全文 | 5920篇 |
免费 | 286篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 193篇 |
妇产科学 | 133篇 |
基础医学 | 1302篇 |
口腔科学 | 101篇 |
临床医学 | 521篇 |
内科学 | 1058篇 |
皮肤病学 | 121篇 |
神经病学 | 556篇 |
特种医学 | 329篇 |
外科学 | 700篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 339篇 |
眼科学 | 71篇 |
药学 | 426篇 |
中国医学 | 4篇 |
肿瘤学 | 341篇 |
出版年
2021年 | 83篇 |
2020年 | 63篇 |
2019年 | 72篇 |
2018年 | 90篇 |
2017年 | 79篇 |
2016年 | 82篇 |
2015年 | 121篇 |
2014年 | 133篇 |
2013年 | 162篇 |
2012年 | 265篇 |
2011年 | 258篇 |
2010年 | 158篇 |
2009年 | 177篇 |
2008年 | 273篇 |
2007年 | 294篇 |
2006年 | 312篇 |
2005年 | 289篇 |
2004年 | 284篇 |
2003年 | 279篇 |
2002年 | 285篇 |
2001年 | 165篇 |
2000年 | 163篇 |
1999年 | 159篇 |
1998年 | 69篇 |
1997年 | 62篇 |
1996年 | 43篇 |
1995年 | 53篇 |
1994年 | 45篇 |
1993年 | 33篇 |
1992年 | 73篇 |
1991年 | 60篇 |
1990年 | 68篇 |
1989年 | 74篇 |
1988年 | 49篇 |
1987年 | 63篇 |
1986年 | 57篇 |
1985年 | 58篇 |
1984年 | 37篇 |
1979年 | 35篇 |
1935年 | 32篇 |
1934年 | 36篇 |
1933年 | 34篇 |
1930年 | 29篇 |
1928年 | 33篇 |
1927年 | 31篇 |
1926年 | 32篇 |
1925年 | 37篇 |
1924年 | 36篇 |
1923年 | 39篇 |
1922年 | 49篇 |
排序方式: 共有6253条查询结果,搜索用时 62 毫秒
101.
Christoph F. Dietrich Adrian Goudie Liliana Chiorean Xin Wu Cui Odd Helge Gilja Yi Dong Jacques S. Abramowicz Sudhir Vinayak Susan Campbell Westerway Christian Pállson Nolsøe Yi-Hong Chou Michael Blaivas 《Ultrasound in medicine & biology》2017,43(1):49-58
Over the last decade, the use of portable ultrasound scanners has enhanced the concept of point of care ultrasound (PoC-US), namely, “ultrasound performed at the bedside and interpreted directly by the treating clinician.” PoC-US is not a replacement for comprehensive ultrasound, but rather allows physicians immediate access to clinical imaging for rapid and direct solutions. PoC-US has already revolutionized everyday clinical practice, and it is believed that it will dramatically change how ultrasound is applied in daily practice. However, its use and teaching are different from continent to continent and from country to country. This World Federation for Ultrasound in Medicine and Biology position paper discusses the current status and future perspectives of PoC-US. Particular attention is given to the different uses of PoC-US and its clinical significance, including within emergency and critical care medicine, cardiology, anesthesiology, rheumatology, obstetrics, neonatology, gynecology, gastroenterology and many other applications. In the future, PoC-US will be more diverse than ever and be included in medical student training. 相似文献
102.
Marina Díaz-Beyá Myriam Labopin Johan Maertens Mahmoud Alijurf Jakob Passweg Beelen Dietrich Harry Schouten Gerard Socié Nicolaas Schaap Rainer Schwerdtfeger Liisa Volin Mauricette Michallet Emmanuelle Polge Jorge Sierra Mohamad Mohty Jordi Esteve Arnon Nagler the Acute Leukaemia Working Party of the European Society for Blood Marrow Transplantation 《British journal of haematology》2020,189(5):920-925
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a poor-risk entity, commonly associated with FLT3-ITD (internal tandem duplication). Allogeneic stem-cell tranplantation (allo-SCT) is recommended, although studies analysing the outcome of allo-SCT in this setting are lacking. We selected 195 patients with t(6;9) AML, who received a first allo-SCT between 2000 and 2016 from the EBMT (European Society for Blood and Marrow Transplantation) registry. Disease status at time of allo-SCT was the strongest independent prognostic factor, with a two-year leukaemia-free survival and relapse incidence of 57% and 19% in patients in CR1 (first complete remission), 34% and 33% in CR2 (second complete remission), and 24% and 49% in patients not in remission, respectively (P < 0·001). This study, which represents the largest one available in t(6;9) AML, supports the recommendation to submit these patients to allo-SCT in CR1. 相似文献
103.
Bernard Barhafumwa Janan Dietrich Kalysha Closson Hasina Samji Angela Cescon Busisiwe Nkala 《Vulnerable children and youth studies》2016,11(3):263-273
Adolescents in HIV endemic settings are a priority demographic with respect to HIV prevention. Some studies have shown that behaviours associated with HIV transmission, may be mediated by mental health factors such as depression. We undertook this study to explore the prevalence and associations of depression symptomology among adolescents living in the HIV endemic community of Soweto, South Africa through the Botsha Bophelo Adolescent Health Study (BBAHS). We estimated the prevalence of depression using the Centre for Epidemiological Studies of Depression Scale, using a score of ≥24 to indicate ‘probable depression’. Among the 789 adolescents (14–19 years) with depression scores, 262 (33%) met the criteria for probable depression (99 [38%] men and 163 [62%] women; p = 0.061). In multivariable logistic regression, factors independently associated with depression included being female (AOR = 2.44, 95% CI: 1.45–4.00), marijuana use (AOR = 2.67, 95% CI: 1.21–5.93), physical violence (AOR = 1.63, 95% CI: 1.01–2.62), pregnancy (AOR = 2.00, 95% CI: 1.03–3.88) and incarceration (AOR = 2.09, 95% CI: 0.99–4.42). These data indicate that a concerning proportion of adolescents in Soweto may be suffering from depression and those screened as potentially depressed, were more likely to be female and have cofactors relating to increased risk for HIV. As part of a comprehensive HIV prevention strategy, we recommend that depression screening for adolescents be integrated into public and school health programs that triage those suffering into treatment programs. 相似文献
104.
Factors Associated with Reported Infection and Lymphedema Symptoms among Individuals with Extremity Lymphedema 下载免费PDF全文
Jie Deng PhD RN OCN Mei R. Fu PhD RN APRN‐BC FAAN Jane M. Armer PhD RN FAAN Janice N. Cormier MD MPH M. Elise Radina PhD CFLE Saskia R.J. Thiadens RN Jan Weiss PT DHS CLT‐LANA Catherine M. Tuppo PT MS CLT‐LANA Mary S. Dietrich PhD Sheila H. Ridner PhD RN FAAN 《Rehabilitation nursing》2015,40(5):310-319
105.
106.
Belete A Desimmie Michael Humbert Eveline Lescrinier Jelle Hendrix Sofie Vets Rik Gijsbers Ruth M Ruprecht Ursula Dietrich Zeger Debyser Frauke Christ 《Molecular therapy》2012,20(11):2064-2075
The interaction between the human immunodeficiency virus (HIV) integrase (IN) and its cellular cofactor lens epithelium-derived growth factor (LEDGF/p75) is crucial for HIV replication. While recently discovered LEDGINs inhibit HIV-1 replication by occupying the LEDGF/p75 pocket in IN, it remained to be demonstrated whether LEDGF/p75 by itself can be targeted. By phage display we identified cyclic peptides (CPs) as the first LEDGF/p75 ligands that inhibit the LEDGF/p75–IN interaction. The CPs inhibit HIV replication in different cell lines without overt toxicity. In accord with the role of LEDGF/p75 in HIV integration and its inhibition by LEDGINs, CP64, and CP65 block HIV replication primarily by inhibiting the integration step. The CPs retained activity against HIV strains resistant to raltegravir or LEDGINs. Saturation transfer difference (STD) NMR showed residues in CP64 that strongly interact with LEDGF/p75 but not with HIV IN. Mutational analysis identified tryptophan as an important residue responsible for the activity of the peptides. Serial passaging of virus in the presence of CPs did not yield resistant strains. Our work provides proof-of-concept for direct targeting of LEDGF/p75 as novel therapeutic strategy and the CPs thereby serve as scaffold for future development of new HIV therapeutics. 相似文献
107.
Prof. Dr. Dietrich Pfeiffer Daniel Jurisch Jens-Gerrit Kluge Andreas Hagendorff Norbert Klein 《Herzschrittmachertherapie & Elektrophysiologie》2014,25(1):26-32
The treatment of atrial fibrillation has to take into account the underlying cardiac and extracardiac diseases. A successful treatment of the underlying disease will only be sufficient treatment of atrial fibrillation in very rare situations. Therefore, this review focuses on the consequences of underlying heart disease, the hemodynamics and concomitant clinical situations on the treatment of atrial fibrillation. 相似文献
108.
Elizabeth A Lungwitz Garret D Stuber Philip L Johnson Amy D Dietrich Nicole Schartz Brian Hanrahan Anantha Shekhar William A Truitt 《Neuropsychopharmacology》2014,39(4):1009-1019
Overcoming specific fears and subsequent anxiety can be greatly enhanced by the presence of familiar social partners, but the neural circuitry that controls this phenomenon remains unclear. To overcome this, the social interaction (SI) habituation test was developed in this lab to systematically investigate the effects of social familiarity on anxiety-like behavior in rats. Here, we show that social familiarity selectively reduced anxiety-like behaviors induced by an ethological anxiogenic stimulus. The anxiolytic effect of social familiarity could be elicited over multiple training sessions and was specific to both the presence of the anxiogenic stimulus and the familiar social partner. In addition, socially familiar conspecifics served as a safety signal, as anxiety-like responses returned in the absence of the familiar partner. The expression of the social familiarity-induced anxiolysis (SFiA) appears dependent on the prefrontal cortex (PFC), an area associated with cortical regulation of fear and anxiety behaviors. Inhibition of the PFC, with bilateral injections of the GABAA agonist muscimol, selectively blocked the expression of SFiA while having no effect on SI with a novel partner. Finally, the effect of D-cycloserine, a cognitive enhancer that clinically enhances behavioral treatments for anxiety, was investigated with SFiA. D-cycloserine, when paired with familiarity training sessions, selectively enhanced the rate at which SFiA was acquired. Collectively, these outcomes suggest that the PFC has a pivotal role in SFiA, a complex behavior involving the integration of social cues of familiarity with contextual and emotional information to regulate anxiety-like behavior. 相似文献
109.
Clinical trials in neurovirology illustrate the special challenges confronting investigators planning to study these conditions, as well as the contributions of successful trials in establishing appropriate management for these devastating diseases. This article reviews key examples of progress in neurovirology that have been spurred by clinical trials, emphasizing human herpes virus encephalitis, HIV, and JC virus. Clinical trials in the setting of neurovirological diseases are characterized by specific challenges, which may include small sample sizes, clinical presentations from life-threatening conditions to chronic courses of disease, regional and temporally restricted outbreaks scenarios, and the unavailability of validated diagnostic tests that can be rapidly deployed at the bedside. This review aims to highlight these methodological challenges and pitfalls in designing and executing clinical neurovirology trials, as well as to outline innovative trial designs, which could be useful in addressing common challenges. 相似文献
110.
Laurent Monassier Estelle Ayme‐Dietrich Gaëlle Aubertin‐Kirch Atul Pathak 《Fundamental & clinical pharmacology》2016,30(2):191-193
The mitochondrial permeability transition (mPTP) is a key feature of cardiac cell death in ischaemia‐reperfusion injury (I/R). The mPTP blocker, cyclosporine A (CsA), has been shown to give protection against reperfusion‐induced myocardial necrosis and troubles generated by acute coronary artery repermeabilization. Nevertheless, the results of the CIRCUS trial (Does Cyclosporine Improve Clinical Outcome in ST‐Elevation Myocardial Infarction Patients) seem to go against this hypothesis. Pharmacological reasons linked to CsA pharmacokinetics and pharmacodynamics could be suggested. First, it could be explained by a limited diffusion of the drug in the area at risk, due to the only inclusion of patients with a TIMI 0 or 1 coronary blood flow in the anterior territory and the absence of collateral perfusion. Second, to explain a low tissue diffusion of the compound, blood cell capture and high metabolism could be suggested. Moreover, CsA is highly metabolized by cytochrome P450 3A4 (CYP3A4), a polymorphic enzyme leading to variations of Cmax and AUC between 10–20% in patients using CsA. Finally, CsA blocks calcineurin, a protein implied in I/R damage but calcineurin inhibition could contribute to protection towards I/R damage only when Rcan1, a calcineurin natural inhibitor, expression is low. The results of the CIRCUS trial are disappointing and could contribute to the withdrawal of the mPTP blockade pharmacological strategy as a way to protect the myocardium from I/R lesions. Nevertheless, many pharmacological insights could have contributed to an increased variability and, as a consequence, an important reduction of the pharmacological power of the study. 相似文献